Form 8-K - Current report:
SEC Accession No. 0001437749-24-019669
Filing Date
2024-06-07
Accepted
2024-06-07 16:16:33
Documents
14
Period of Report
2024-06-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K plse20240607_8k.htm   iXBRL 8-K 30948
  Complete submission text file 0001437749-24-019669.txt   163845

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA plse-20240606.xsd EX-101.SCH 3408
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plse-20240606_def.xml EX-101.DEF 11423
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE plse-20240606_lab.xml EX-101.LAB 15309
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plse-20240606_pre.xml EX-101.PRE 11583
17 EXTRACTED XBRL INSTANCE DOCUMENT plse20240607_8k_htm.xml XML 2823
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 241029657
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)